FDA hustles through a quick OK for Shionogi's new thrombocytopenia drug
The FDA has whisked through a new drug for thrombocytopenia patients.
The therapy is lusutrombopag (Mulpleta), which handily beat the August 26 PDUFA date that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
